| Issue Date | Title | Author(s) | Citation |
| 2016 | Continuing variation and barriers to nurse-led vaginal dilator education for women with gynaecological cancer receiving radiotherapy | Juraskova, Ilona; Aranda, Sanchia; Bergin, Rebecca; Bernshaw, David; Hocking, Alison; Kabel, Donna; Mileshkin, Linda; Robinson, Taryn; Schofield, Penelope; Psychology | Continuing variation and barriers to nurse-led vaginal dilator education for women with gynaecological cancer receiving radiotherapy, European Journal of Oncology Nursing, vol.24, N/A, 2016,pp 20-21 |
| 2016 | Developing an evidence-based, nurse-led psychoeducational intervention with peer support in gynecologic oncology | Juraskova, Ilona; Aranda, Sanchia; Bergin, Rebecca; Bernshaw, David; Grogan, Suzi; Hocking, Alison; Krishnasamy, Meinir; Mileshkin, Linda; Penberthy, Sylvia; Schofield, Penelope; Psychology | Developing an evidence-based, nurse-led psychoeducational intervention with peer support in gynecologic oncology, Cancer Nursing, vol.39, 2, 2016,pp E19-E30 |
| 2017 | Discussing and prescribing expensive unfunded anticancer drugs in Australia | Karikios, Deme; Martin, Andrew; Stockler, Martin; Ferraro, Danielle; Mileshkin, Linda; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre | Discussing and prescribing expensive unfunded anticancer drugs in Australia, ESMO Open, vol.2, 2, 2017,pp 1-7 |
| 2015 | Geriatric assessment of older patients with cancer in Australia-A multicentre audit | Marx, Gavin; Tattersall, Martin; Della Fiorentina, Stephen; Dunlop, Tracey; et al, Various; Hovey, Elizabeth; Joshi, Sachin; Lakhanpal, Roopa; Liew, Sem; Mileshkin, Linda; Venkateswaran, Lakshmi; Yip, Desmond; Yoong, Jaclyn; Medicine; Central Clinical School: Medicine | Geriatric assessment of older patients with cancer in Australia-A multicentre audit, Journal of Geriatric Oncology, vol.6, 3, 2015,pp 185-193 |
| 2014 | Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS) | deFazio, Anna; Au-Yeung, George; Bressel, Mathias; Feredaye, Sian; Mileshkin, Linda; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute | Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS), Gynecologic Oncology, vol.133, 1, 2014,pp 16-22 |
| 2013 | A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trial | Juraskova, Ilona; White, Kathryn; Aranda, Sanchia; Bergin, Rebecca; Bernshaw, David; Gough, Karla; Krishnasamy, Meinir; Mileshkin, Linda; Penberthy, Sylvia; Schofield, Penelope; Psychology; Faculty of Nursing & Midwifery | A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trial, Trials, vol.14, 1, 2013,pp 1-11 |
| 2017 | Paragon (ANZGOG-0903): Phase 2 study of anastrozole in women with estrogen or progesterone receptorypositive platinum-resistant or -refractory recurrent ovarian cancer | Beale, Philip; deFazio, Anna; Friedlander, Michael; Mapagu, Cristina; Martyn, Julie; Mileshkin, Linda; O'Connell, Rachel; Sjoquist, Katrin; Bonaventura, Anthony; Goh, J; Grant, Peter; Hadley, Alison; McNally, Orla; Scurry, James P; Central Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; Childrens Hospital Westmead: Paediatrics & Child Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre | Paragon (ANZGOG-0903): Phase 2 study of anastrozole in women with estrogen or progesterone receptorypositive platinum-resistant or -refractory recurrent ovarian cancer, International Journal of Gynecological Cancer, vol.27, 5, 2017,pp 900-906 |
| 2016 | Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial | Blinman, Prunella; Kolodziej, Ilka; O'Connell, Rachel; Stockler, Martin; Wain, Gerard; Brooks, Susan; Capp, A.; et al, Various; Goss, Geraldine; Johnson, Carol; Khaw, Pearly; Mileshkin, Linda; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Obstetrics & Gynaecology | Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial, British Journal of Cancer, vol.115, 10, 2016,pp 1179-1185 |
| 2016 | Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial | Blinman, Prunella; Kolodziej, Ilka; O'Connell, Rachel; Stockler, Martin; Wain, Gerard; Brooks, Susan; Capp, A.; et al, Various; Goss, Geraldine; Johnson, Carol; Khaw, Pearly; Mileshkin, Linda; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Obstetrics & Gynaecology | Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial, British Journal of Cancer, vol.115, 10, 2016,pp 1179-1185 |
| 2017 | Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists | Gooden, Helen; Robotin, Monica; Tattersall, Martin; Guccione, Lisa; Karapetis, Christos; Lambert, Sylvie; Mileshkin, Linda; Schofield, Penelope; Vajdic, Claire M.; Faculty of Nursing & Midwifery; School of Public Health: Public Health; Central Clinical School: Medicine | Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists, Internal Medicine Journal, vol.47, 4, 2017,pp 408-414 |
| 2016 | PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer | Lindemann, Kristina; Martyn, Julie; Willson, Melina; Mileshkin, Linda; Roncolato, Felicia; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre | PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer, Cochrane Database of Systematic Reviews, vol.2016, 4, 2016,pp N/A-N/A |
| 2016 | Results of the Australasian (Trans-Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC-3 trial | Do, Viet; Foo, Kerwyn; Holloway, Lois; Bailey, Michael; Creutzberg, Carien; Jameson, Michael; Khaw, Pearly; McNamara, Jo; Metcalfe, Peter; Mileshkin, Linda; Nepean Clinical School: Medicine; Central Clinical School: Medicine; Physics | Results of the Australasian (Trans-Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC-3 trial, Journal of Medical Imaging and Radiation Oncology, vol.60, 4, 2016,pp 554-559 |
| 2015 | Weighing up the benefits and harms of a new anti-cancer drug - a survey of Australian oncologists | Chim, Lesley; Salkeld, Glenn; Stockler, Martin; Mileshkin, Linda; School of Public Health: Public Health; School of Public Health: Public Health; NH&MRC Clinical Trials Centre | Weighing up the benefits and harms of a new anti-cancer drug - a survey of Australian oncologists, Internal Medicine Journal, vol.45, 8, 2015,pp 834-842 |